Exploring synthetic controls in rare diseases with a proof of concept in spinal cord injury

Background: Successfully completing clinical trials for rare and heterogeneous disorders, like spinal cord injuries (SCI), remains challenging, thereby reducing the ability to test and translate promising preclinical findings. We propose synthetic controls, derived from data-driven predictions of re...

Full description

Saved in:
Bibliographic Details
Main Authors: Lukas, Louis (Author) , Håkansson, Samuel (Author) , Tuci, Miklovana (Author) , Torres-Espín, Abel (Author) , Rupp, Rüdiger (Author) , Taran, Olga (Author) , Weidner, Norbert (Author) , Geisler, Fred (Author) , Schubert, Martin (Author) , Röhrich, Frank (Author) , Kalke, Yorck B. (Author) , Abel, Rainer (Author) , Maier, Doris (Author) , Chhabra, Harvinder S. (Author) , Liebscher, Thomas (Author) , Kramer, John L. K. (Author) , Bolliger, Marc (Author) , Curt, Armin (Author) , Jutzeler, Catherine R. (Author) , Brüningk, Sarah C. (Author)
Format: Article (Journal)
Language:English
Published: 24 October 2025
In: BMC medicine
Year: 2025, Volume: 23, Pages: 1-13
ISSN:1741-7015
DOI:10.1186/s12916-025-04405-3
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12916-025-04405-3
Get full text
Author Notes:Louis P. Lukas, Samuel Håkansson, Miklovana Tuci, Abel Torres-Espín, Rüdiger Rupp, Olga Taran, Norbert Weidner, Fred Geisler, Martin Schubert, Frank Röhrich, Yorck B. Kalke, Rainer Abel, Doris Maier, Harvinder S. Chhabra, Thomas Liebscher, EMSCI study group, John L.K. Kramer, Marc Bolliger, Armin Curt, Catherine R. Jutzeler and Sarah C. Brüningk

MARC

LEADER 00000naa a2200000 c 4500
001 1946351032
003 DE-627
005 20251217125442.0
007 cr uuu---uuuuu
008 251217s2025 xx |||||o 00| ||eng c
024 7 |a 10.1186/s12916-025-04405-3  |2 doi 
035 |a (DE-627)1946351032 
035 |a (DE-599)KXP1946351032 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lukas, Louis  |e VerfasserIn  |0 (DE-588)138459292X  |0 (DE-627)1946353140  |4 aut 
245 1 0 |a Exploring synthetic controls in rare diseases with a proof of concept in spinal cord injury  |c Louis P. Lukas, Samuel Håkansson, Miklovana Tuci, Abel Torres-Espín, Rüdiger Rupp, Olga Taran, Norbert Weidner, Fred Geisler, Martin Schubert, Frank Röhrich, Yorck B. Kalke, Rainer Abel, Doris Maier, Harvinder S. Chhabra, Thomas Liebscher, EMSCI study group, John L.K. Kramer, Marc Bolliger, Armin Curt, Catherine R. Jutzeler and Sarah C. Brüningk 
264 1 |c 24 October 2025 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 24. Oktober 2025 
500 |a Gesehen am 17.12.2025 
520 |a Background: Successfully completing clinical trials for rare and heterogeneous disorders, like spinal cord injuries (SCI), remains challenging, thereby reducing the ability to test and translate promising preclinical findings. We propose synthetic controls, derived from data-driven predictions of recovery in patients undergoing standard treatments, to mitigate these challenges, in particular related to patient recruitment. Methods: Based on data from the European Multicenter Study about Spinal Cord Injury (EMSCI) and the Sygen trial, we construct synthetic controls from personalized predictions of neurological recovery of sequences of segmental motor scores. A total of six architectures (linear, tree, and deep learning models) are compared. We demonstrate the applicability of synthetic controls through a simulation framework modeling the randomization process in a clinical trial and a case study that re-evaluates the recently completed Nogo Inhibition in SCI (NISCI) trial as a single-arm trial post hoc. Results: The primary dataset included 4196 patients from EMSCI and 587 patients from the Sygen trial for external validation. We identified a convolutional neural network as the best-performing architecture to predict segmental motor score sequences, achieving a median root mean squared error below the neurological level of injury of 0.55. Our trial simulations demonstrate that synthetic controls are a viable alternative to randomization, as the proposed solution reduces intercohort heterogeneity and leads to no significant differences with randomized controls in our case study reassessing a clinical trial. Conclusions: We provide a comprehensive benchmark of data-driven prediction architectures for neurological recovery after SCI. Apart from offering individual patients a specific recovery prediction, these models constitute the basis for synthetic controls. Using real-world data from a completed trial in SCI, we show that synthetic controls could mitigate the challenges of small cohorts and patient recruitment in rare disorders, offering the opportunity to maximize the number of patients receiving an investigative treatment. 
650 4 |a Clinical trial design 
650 4 |a Machine learning 
650 4 |a Recovery prediction 
700 1 |a Håkansson, Samuel  |e VerfasserIn  |4 aut 
700 1 |a Tuci, Miklovana  |e VerfasserIn  |4 aut 
700 1 |a Torres-Espín, Abel  |e VerfasserIn  |4 aut 
700 1 |a Rupp, Rüdiger  |d 1969-  |e VerfasserIn  |0 (DE-588)135739608  |0 (DE-627)570578388  |0 (DE-576)281757496  |4 aut 
700 1 |a Taran, Olga  |e VerfasserIn  |4 aut 
700 1 |a Weidner, Norbert  |e VerfasserIn  |0 (DE-588)1035265907  |0 (DE-627)747116326  |0 (DE-576)176492577  |4 aut 
700 1 |a Geisler, Fred  |e VerfasserIn  |4 aut 
700 1 |a Schubert, Martin  |e VerfasserIn  |4 aut 
700 1 |a Röhrich, Frank  |e VerfasserIn  |4 aut 
700 1 |a Kalke, Yorck B.  |e VerfasserIn  |4 aut 
700 1 |a Abel, Rainer  |e VerfasserIn  |4 aut 
700 1 |a Maier, Doris  |e VerfasserIn  |4 aut 
700 1 |a Chhabra, Harvinder S.  |e VerfasserIn  |4 aut 
700 1 |a Liebscher, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Kramer, John L. K.  |e VerfasserIn  |4 aut 
700 1 |a Bolliger, Marc  |e VerfasserIn  |4 aut 
700 1 |a Curt, Armin  |e VerfasserIn  |4 aut 
700 1 |a Jutzeler, Catherine R.  |e VerfasserIn  |4 aut 
700 1 |a Brüningk, Sarah C.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t BMC medicine  |d London : BioMed Central, 2003  |g 23(2025), Artikel-ID 581, Seite 1-13  |h Online-Ressource  |w (DE-627)377271225  |w (DE-600)2131669-7  |w (DE-576)121906655  |x 1741-7015  |7 nnas  |a Exploring synthetic controls in rare diseases with a proof of concept in spinal cord injury 
773 1 8 |g volume:23  |g year:2025  |g elocationid:581  |g pages:1-13  |g extent:13  |a Exploring synthetic controls in rare diseases with a proof of concept in spinal cord injury 
856 4 0 |u https://doi.org/10.1186/s12916-025-04405-3  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20251217 
993 |a Article 
994 |a 2025 
998 |g 1035265907  |a Weidner, Norbert  |m 1035265907:Weidner, Norbert  |d 910000  |d 911400  |e 910000PW1035265907  |e 911400PW1035265907  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 135739608  |a Rupp, Rüdiger  |m 135739608:Rupp, Rüdiger  |d 910000  |d 911400  |d 50000  |e 910000PR135739608  |e 911400PR135739608  |e 50000PR135739608  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 5 
999 |a KXP-PPN1946351032  |e 4829616210 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Veröffentlicht: 24. Oktober 2025","Gesehen am 17.12.2025"],"id":{"doi":["10.1186/s12916-025-04405-3"],"eki":["1946351032"]},"relHost":[{"recId":"377271225","note":["Gesehen am 29.10.13"],"id":{"issn":["1741-7015"],"eki":["377271225"],"zdb":["2131669-7"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Exploring synthetic controls in rare diseases with a proof of concept in spinal cord injuryBMC medicine","language":["eng"],"part":{"year":"2025","volume":"23","extent":"13","pages":"1-13","text":"23(2025), Artikel-ID 581, Seite 1-13"},"pubHistory":["1.2003 -"],"title":[{"title_sort":"BMC medicine","title":"BMC medicine"}],"origin":[{"dateIssuedKey":"2003","publisherPlace":"London ; Berlin ; Heidelberg [u.a.]","publisher":"BioMed Central ; Springer","dateIssuedDisp":"2003-"}]}],"name":{"displayForm":["Louis P. Lukas, Samuel Håkansson, Miklovana Tuci, Abel Torres-Espín, Rüdiger Rupp, Olga Taran, Norbert Weidner, Fred Geisler, Martin Schubert, Frank Röhrich, Yorck B. Kalke, Rainer Abel, Doris Maier, Harvinder S. Chhabra, Thomas Liebscher, EMSCI study group, John L.K. Kramer, Marc Bolliger, Armin Curt, Catherine R. Jutzeler and Sarah C. Brüningk"]},"language":["eng"],"recId":"1946351032","type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"24 October 2025","dateIssuedKey":"2025"}],"person":[{"family":"Lukas","display":"Lukas, Louis","role":"aut","given":"Louis","roleDisplay":"VerfasserIn"},{"given":"Samuel","roleDisplay":"VerfasserIn","role":"aut","family":"Håkansson","display":"Håkansson, Samuel"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Miklovana","display":"Tuci, Miklovana","family":"Tuci"},{"roleDisplay":"VerfasserIn","given":"Abel","role":"aut","family":"Torres-Espín","display":"Torres-Espín, Abel"},{"roleDisplay":"VerfasserIn","given":"Rüdiger","role":"aut","display":"Rupp, Rüdiger","family":"Rupp"},{"family":"Taran","display":"Taran, Olga","role":"aut","given":"Olga","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Norbert","family":"Weidner","display":"Weidner, Norbert"},{"roleDisplay":"VerfasserIn","given":"Fred","role":"aut","display":"Geisler, Fred","family":"Geisler"},{"display":"Schubert, Martin","family":"Schubert","given":"Martin","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Frank","roleDisplay":"VerfasserIn","role":"aut","display":"Röhrich, Frank","family":"Röhrich"},{"display":"Kalke, Yorck B.","family":"Kalke","given":"Yorck B.","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Rainer","roleDisplay":"VerfasserIn","role":"aut","display":"Abel, Rainer","family":"Abel"},{"given":"Doris","roleDisplay":"VerfasserIn","role":"aut","display":"Maier, Doris","family":"Maier"},{"display":"Chhabra, Harvinder S.","family":"Chhabra","given":"Harvinder S.","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Thomas","roleDisplay":"VerfasserIn","role":"aut","display":"Liebscher, Thomas","family":"Liebscher"},{"family":"Kramer","display":"Kramer, John L. K.","roleDisplay":"VerfasserIn","given":"John L. K.","role":"aut"},{"given":"Marc","roleDisplay":"VerfasserIn","role":"aut","display":"Bolliger, Marc","family":"Bolliger"},{"role":"aut","given":"Armin","roleDisplay":"VerfasserIn","family":"Curt","display":"Curt, Armin"},{"family":"Jutzeler","display":"Jutzeler, Catherine R.","role":"aut","roleDisplay":"VerfasserIn","given":"Catherine R."},{"display":"Brüningk, Sarah C.","family":"Brüningk","role":"aut","roleDisplay":"VerfasserIn","given":"Sarah C."}],"physDesc":[{"extent":"13 S."}],"title":[{"title":"Exploring synthetic controls in rare diseases with a proof of concept in spinal cord injury","title_sort":"Exploring synthetic controls in rare diseases with a proof of concept in spinal cord injury"}]} 
SRT |a LUKASLOUISEXPLORINGS2420